|
No. |
Name |
Institution |
Project Name |
Patient No. |
Approval date |
|
103001 |
Lin-Tsing Chen |
Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital |
Tumor Biology of Hepatocellular Carcinoma |
90 |
20141226 |
|
104002 |
Su-Fang Lin |
National Institute of Cancer Research, National Health Research Institutes, Taiwan |
FGFR2 gene fusion in Taiwanese intrahepatic cholangiocarcinoma tissues |
90 |
20150306 |
|
104003 |
Yoa-Pu Hu |
Department of Pharmacy, National Defense Medical Center |
Function and expression of drug transporters dictate the different rosuvastatin systemic exposure between Asians and Caucasians |
40 |
20150508 |
|
104004 |
Dar-In Tai |
Gastroenterology and hepatology, Chang Gung Memorial Hospital |
Human genetic polymorphism in therapeutic response of chronic hepatitis B |
1000 |
20150731 |
|
104005 |
Sen-Yung Hsieh |
Chang Gung Memorial Hospital |
In vivo functional genomics to decipher the genes/mechanisms orchestrating hepatoma invasion |
180 |
20150731 |
|
104006 |
Yun-Ru Liu |
Joint Biobank, Taipei Medical University |
The association analysis of a histone mRNA as a new biomarker of HCC recurrence |
92 |
20151005 |
|
104007 |
Hsu Shih-Hsien |
KMU |
To explore the regulatory effect of aryl hydrocarbon receptor (AhR) on initiation and enhance role of oncoprotein ISX in human hepatocellular carcinoma (HCC) |
200 |
20151005 |
|
104008 |
Pei-Jer Chen |
Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine |
Development of new treatment and biomarker for hepatocellular carcinoma: from woodchuck to human (3/3) |
120 |
20151005 |
|
104009 |
Wan-long Chuang |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
HCV infection affects on growth hormone signaling pathway in liver diseases and hepatocellular carcinoma progression |
200 |
20151207 |
|
105010 |
Yi-Hsiang Liu Chiung-Chi Cheng |
Chang Bing Show Chwan Memorial Hospital |
Differential expression of the cytoskeleton proteins and the plectin in human hepatocellular carcinoma versus liver cells and in cholangicarcinoma versus bile duct epithelium |
120 |
20160121 |
|
105011 |
Yuh-Shan Jou |
Institute of Biomedical Sciences ,Academia Sinica |
Dissecting molecular mechanisms of PSPC1 overexpression driven cancer EMT, stemness and tumor metastasis. |
200 |
20160121 |
|
105012 |
Pei-Jer Chen |
Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine |
Development of new treatment and biomarker for hepatocellular carcinoma: from woodchuck to human (3/3) |
120 |
20160121 |
|
105013 |
Yi-Hsiang Huang |
Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital |
The Role of Tid1 Expression in Behavior and Prognosis of hepatocellular Carcinoma |
200 |
20160325 |
|
105014 |
Chiun Hsu |
National Taiwan University Hospital |
Incorporation of genomic and immunological studies for biomarker identification for hepatocellular carcinoma |
600 |
20160325 |
|
105015 |
Jui-Hsiang Hung |
Department of Biotechnology, Chia Nan University of Pharmacy and Science |
To investigate the effect of nucleobindin-2 overexpression by endoplasmic reticulum stress on hepatocellular carcinoma treatment |
120 |
20160503 |
|
105016 |
Kwang-Huei Lin |
Graduate Institutes of Biomedical Sciences, Chang Gung University |
Characterization the physiological significance of angiogenesis associated gene regulated thyroid hormone |
160 |
20160503 |
|
105017 |
Shih-Feng Tsai |
Institute of Molecular and Genomic Medicine, National Health Research Institutes |
Translational research on genomic variations in liver cancer |
250 |
20160503 |
|
105018 |
Alice L. Yu |
Institute of Stem Cell and Translational Cancer Research, Linkou Chang Gung Memorial Hospital |
Tumor Biology of Hepatocellular carcinoma |
90 |
20160725 |
|
105019 |
I-Cheng Lee |
Division of Gastroenterology and Hepatology, Department of Medicine ,Taipei Veterans General Hospital |
The Role of Host Immune Regulators and Tumor Microenvironment in the Prognosis of Hepatocellular Carcinoma |
200 |
20160919 |
|
105020 |
Yu-Tsung Shih |
Institute of Cellular and System medicine, National Health Research Institutes |
Unrevealing the Metabolic Abnormalities of Endothelial Cells in Response to the Angiogenic Niche Composed by Endothelial Progenitors and Hepatocarcinoma Cells |
24 |
20160919 |
|
105021 |
Shiou-Hwei Yeh |
Dept. of Microbiology, College of Medicine, National Taiwan University |
The distribution trend of Glypican-3 expression in hepatocellular carcinoma |
120 |
20160919 |
|
105022 |
Li Ching Li |
Shuang Ho Hospital, Taipei Medical University |
Investigation of nicotine/cigarette-smoke promotes metastasis of hepatocellular carcinoma through nAChR and pre-clinically evaluation of correlation between smoking and hepatocellular carcinoma |
180 |
20161128 |
|
105023 |
Chiun Hsu |
National Taiwan University Hospital |
Incorporation of genomic and immunological studies for biomarker identification for hepatocellular carcinoma |
800 |
20161128 |
|
106024 |
Hsieh, Shie-Liang |
Genomics Research Center, Academia Sinica |
Liver and plasma C-type lectin 18 (CLEC18) expression in hepatitis B and C virus infected patients |
260 |
20170209 |
|
106025 |
Hsiung, Chao Agnes |
Institute of Population Health Sciences, National Health Research Institutes |
Using EGFR mutation status and germline genetic variants jointly to make decision for treating late-stage lung adenocarcinoma patients － a prospective study |
220 |
20170209 |
|
106026 |
Yi-mimg Chen |
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University |
A study of the epigenetic regulation of GNMT gene expression and the role GNMT plays in the control of global DNA methylation |
80 |
20170209 |
|
106027 |
Jung-Jyh Hung |
Division of Thoracic Surgery, Taipei Veterans General Hospital |
Identification of genes related to metastasis and their regulating mechanisms in lung cancer by combination of pathological subtypes and gene expression in microarray (II) |
120 |
20170209 |
|
106028 |
Pei-Jer Chen |
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University |
Taiwan Research Biosignature Network on Patients at High Risk of Hepatocellular Carcinoma (TARGET-HCC) |
60 |
20170419 |
|
106029 |
Hsien-Chung Yu |
Division of Gastroenterology and Hepatobiliary, Department of Internal Medicine, Kaohsiung Veterans General Hospital |
The correlation between serum BioFibroScore, Pre-S Deletion and Histological Fibrosis in Chronic Hepatitis B Patients with Hepatocellular Carcinoma Receiving Curative Resection |
150 |
20170419 |
|
106030 |
Tung-Hung Su |
Internal Medicine, National Taiwan University Hospital |
Clinical implications of immunophenotypes in liver fibrosis and hepatocellular carcinoma |
150 |
20170612 |
|
106031 |
Shih-Feng Tsai |
Institute of Molecular and Genomic Medicine, National Health Research Institutes |
Flagship program of precision medicine for Asiapacific Biomedical Silicon Valley |
200 |
20170811 |
|
106032 |
Chau-Ting Yeh |
Liver Research Center, Chang-Gung Memorial Hospital |
Clinical and molecular characterization of hepatocellular carcinoma carrying distinct patterns of HBV S gene truncation mutations |
11 |
20170612 |
|
106033 |
Yan-Hwa Wu Lee |
Department of Biological Science and Technology, National Chiao-Tung University |
Functional roles of DDX3 in regulating exosome biogenesis and its therapeutic potential on hepatic tumorigenesis |
75 |
20170811 |
|
106034 |
Chau-Ting Yeh |
Liver Research Center, Chang-Gung Memorial Hospital |
Clinical and molecular characterization of hepatocellular carcinoma carrying distinct patterns of HBV S gene truncation mutations |
200 |
20170811 |
|
106035 |
Chia-Hung Yen |
Graduate Institute of Natural Products, Kaohsiung Medical University |
A study of the role of redox state in the development of sarcomatoid hepatocellular carcinoma and its application in antiliver cancer drug discovery |
120 |
20171020 |
|
106036 |
Jun-Yang Liou |
Institute of Cellular and System Medicine, National Health Research Institutes |
To investigate the role of AKR1B10 expression and metabolism in regulating epithelial-mesenchymal transition and drug resistance of hepatocellular carcinoma |
150 |
20171222 |
|
106037 |
Li-Fen Shen |
Drug Development Division, TaiRx,Inc. |
A Pilot Study of Tumor Prognostic Biomarker in Hepatocellular Carcinoma |
120 |
20180205 |
|
106038 |
Jun-Yang Liou |
Institute of Cellular and System Medicine, National Health Research Institutes |
To investigate the role of AKR1B10 expression and metabolism in regulating epithelial-mesenchymal transition and drug resistance of hepatocellular carcinoma |
150 |
20180205 |
|
107039 |
Jyh-Lyh Juang |
Institute of Molecular and Genomic Medicine,National Health Research Institutes |
Identification of potential mechanism for liver cancer in tumor tissue |
50 |
20180409 |
|
107040 |
Mei-Hwei Chang |
Pediatrics,National Taiwan University College of Medicine |
Long-term Follow-up of Chronic Hepatitis B Virus Infection from Mother-to-Infant Transmission to Adult Life |
50 |
20180409 |
|
107041 |
Jinn-Moon Yang |
Institute of Bioinformatics and System Biology,National Chiao Tung Tung University |
Intelligent Computing Precision Medical and Drug Development Platform – Integrated dynamic systems biology models to study the mechanisms between diabetes mellitus and liver cancer for developing biomarkers and drugs |
120 |
20180409 |
|
107042 |
Yan-Hwa Wu Lee |
Department of Biological Science and Technology, National ChiaoTung University |
Center for Intelligent Drug Systems and Smart Bio-devices, IDS2B |
30 |
20180409 |
|
107043 |
Yue-Liang Guo |
National Institute of Environmental Health sciences,National Health Research Institute |
Air pollutants and hepatocellular carcinoma survival |
1000 |
20180927 |
|
107044 |
Jui-Hsiang Hung |
Department of Biotechnology,Chia Nan University of Pharmacy and Science |
To investigate the mechanism of endoplasmic reticulum stress-induced nucleobindin-2 expression and its effect on the treatment of liver cancer |
120 |
20180626 |
|
107045 |
Pei-Jer Chen |
Graduate institute of Clinical Medicine,College of Medicine,National Taiwan University |
Taiwan Research Biosignature Network on Patients at High Risk of Hepatocellular Carcinoma(TARGET-HCC) |
50 |
20180626 |
|
107046 |
Hsu Shih-Hsien |
Graduate Institute of Medicine,Kaohsiung Medical University |
To explore the potential regulatory mechanism and clinical outcomes of epigenetic modulator, PCAF, on oncogenic transcriptional complex, ISX-Brd4-RNA pol II complex in lung cancer |
50 |
20180829 |
|
107047 |
Hsiung CA |
Institute of Population Health Sciences,National Health Research Institutes |
Biomarker Development for Lung Adenocarcinoma Risk Prediction and Drug Response |
300 |
20180829 |
|
107048 |
Jyh-Lyh Juang |
Institute of Molecular and Genomic Medicine, National Health Research Institutes |
Indentification of potential mechanism for liver cancer in tumor tissue |
40 |
20181220 |
|
107049 |
Mei-Hwei Chang |
Prediatrics,National Taiwan University College of Medicine |
Long-term Follow-up of Chronic Hepatitis B Vitus Infection from Mother-to-Infant Transmission to Adult Life |
150 |
20181220 |
|
107050 |
Ma,Wen-Lung |
Graduate Institute of BioMedical Sciences,China medical university |
Study of the metabolic syndrome-related VLDL and VLDLR roles in hepatocellular carcinoma |
225 |
20181220 |
|
108051 |
Tzu-Ling Tseng |
Bio Preventive Medicine Corp. |
Cancer biomarkers development |
60 |
20190227 |
|
108052 |
Chi-Ying Huang |
Institute of Biopharmaceutical Sciences,National Yang-Ming University |
The prognostic correlation of exosomal GPC3 level at diagnosis,surveillance and survival of patients with hepatocellular carcinoma |
50 |
20190227 |
|
108053 |
Chao-Wei Hsu |
Division of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital |
Clinical and Functional Significance of infections of Genetically Different Hepatitis Delta Virus |
300 |
20190227 |
|
108054 |
Mei-Hwei Chang |
Pediatric,National Taiwan University College of Medicine |
Long-term Follow-up of Chronic Hepatitis B Virus Infection from Mother-to-Infant Transmission to Adult Life |
100 |
20190227 |
|
108055 |
Yan-Hwa Wu Lee |
Department of Biological Science and Technology, National Chiao Tung University |
Center for Intelligent Drug Systems and Smart Bio-devices, IDS2B |
50 |
20190424 |
|
108056 |
Shih-Feng Tsai |
Institute of Molecular and Genomic Medicine, National Health Research Institutes |
Translational research on genomic variations in liver cancer |
150 |
20190424 |
|
108057 |
Ling-Yueh Hu |
Laboratory of Translational Medicine Office, Development Center for Biotechnology |
Explore the expression and distribution of the immune checkpoint related proteins in normal liver tissue |
40 |
20190625 |
|
108058 |
George Wei |
Clinical Project Management Dep. ACT Genomics Co., Ltd. |
To Study the Association between Mutational Spectrum/Tumor Microenvironment and Prognosis in HCC/CC Using Archived Specimens |
300 |
20190625 |
|
108059 |
Ting-Fen Tsai |
Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University |
Development of novel therapeutics for non-alcoholic fatty liver diseases (NAFLD) and steatohepatitis (NASH) |
170 |
20190820 |
|
108060 |
Yang-Hsiang Lin |
Liver Research Center, Chang Gung Memorial Hospital, Linkou |
Characterization of LOC731656 functions in human hepatocellular carcinoma and its clinical significance |
80 |
20190820 |
|
108061 |
Lee, Mei-Hsuan |
Institute of Clinical Medicine, National Yang Ming University |
DNA methylation profiling, antigen representation of HLA and associated risk for hepatocellular carcinoma |
900 |
20191007 |
|
108062 |
Sen-Yung Hsieh |
Dept. of Gastroenterology & Hepatology, Linkou Chang Gung Memorial Hospital |
Decipher genomic and epigenomic alternations in the liver and digestive cancers |
108 |
20191007 |
|
108063 |
Yan-Hwa Wu Lee |
Department of Biological Science and Technology, National Chiao Tung University |
Center for Intelligent Drug Systems and Smart Bio-devices, IDS2B |
30 |
20191213 |
|
108064 |
JAW-CHING WU |
Institute of Clinical Medicine, National Yang Ming University |
Investigating the regulatory mechanism of glycosphingolipids in Hepatitis B virus-transgenic mice and human liver cancer specimens for the development of novel diagnostic and therapeutic strategies for Hepatocellular carcinoma |
680 |
20200213 |
|
108065 |
Sheng-Hui Lan |
Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University |
Physiologic and pathologic roles of FUS for microRNA turnover by selective autophagy |
16 |
20200213 |
|
109066 |
Jun-Yang Liou |
Institute of Cellular and System Medicine, National Health Research Institutes |
Characterization of HIOMT isoform for 5-MTP biosynthesis and its defect in cancer |
150 |
20200422 |
|
109067 |
Shun-Fa Yang |
Department of Medical Research, Chung Shan Medical University Hospital |
Study of the LncRNA genetic variants in hepatocellular carcinoma |
400 |
20200422 |
|
109068 |
Chao-Wei Hsu |
Division of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital |
Clinical and Functional Significance of Infections of Genetically Different Hepatitis Delta Virus |
8 |
20200422 |
|
109069 |
Tsai, Jih-Jin |
Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital |
Research and development of COVID-19 precision diagnostics |
30 |
20200422 |
|
109070 |
Ho Ming-Chih |
Surgery, National Taiwan University Hospital |
Specific HBV-human chimera DNA as a novel biomarker for predicting the outcome of HCC after transplantation (2) |
136 |
20200520 |
|
109071 |
Chao-Cheng Haung |
Pathology, Kaoshiung Chang Gung Memorial Hospital |
Investigating the Role of Delta-like 1 Homolog (DLK1) in T Cell Immune Surveillance of Hepatocellular Carcinoma |
80 |
20200520 |
|
109072 |
Kuo-Shyang Jeng |
General Surgery, Far Eastern Memorial Hospital |
To investigate the role of inhibition of sonic Hedgehog signaling pathway in increasing the sensitivity of doxorubicin in hepatocellular carcinoma-an in vitro and in vivo study |
20 |
20200520 |
|
109073 |
Lin Ming-Tsung |
Kaohsiung Chang Gung Memorial Hospital |
Biomarkers analysis for hepatocellular carcinoma and liver fibrosis |
20 |
20200520 |
|
109074 |
Kuo Kuang-Tai |
Thoracic surgery, Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare |
Targeting the BTK-ITK axis as a potential therapeutic strategy for overcoming drug resistance and inhibiting brain metastasis in lung cancer |
48 |
20200520 |
|
109075 |
Jian-Xun Chen |
Thoracic Surgery, China Medical University Hospital |
Exploring the clinical significance of multi-omic markers of lung cancer |
75 |
20200610 |
|
109076 |
Kelvin Kunchih Tsai |
Graduate institute of Clinical Medicine / Division of Gastroenterology, Department of Internal Medicine, Taipei Medical University / Taipei Municipal Wan Fang Hospital |
The role of ASPM-Wnt signaling in hepatoma cancer stemness and progression and the development of the related nano- and gene-therapy |
100 |
20200610 |
|
109077 |
Kao, Ming-wei |
Thoracic Surgery, E-Da Hospital |
Gene expressions of vasculogenic mimicry in lung adenocarcinoma |
50 |
20200610 |
|
109078 |
CHEN YAW- SEN |
Department of Surgery, E-Da Hospital |
To study amino-acid-dependent GATORC1/mTORC1 signaling in the development of hepatocellular carcinoma |
90 |
20200610 |
|
109079 |
Chang Wei Li |
AllBio Science, Inc |
The COVID-19 rapid test development |
35 |
20200610 |
|
109080 |
Guan-Da Syu |
Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University |
Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray |
110 |
20201028 |
|
109081 |
Liang-Tzung Lin |
Microbiology and Immunology, Taipei Medical University |
Establishment of SARS-CoV-2 Pseudoparticle System as Diagnostic and Therapeutic Testing Platform |
10 |
20200714 |
|
109082 |
Chen, Shao-Yuan |
Laboratory of Translational Medicine Office, Development Center for Biotechnology |
Explore the impact of signal transduction factors in tumor progression |
90 |
20200714 |
|
109083 |
Yen-Hui Chiu |
Department of Technology, Union Clinical Laboratory |
Analytical validation of commercial mutation detection systems in clinical specimens |
100 |
20200714 |
|
109084 |
Hsieh, Ching-Hua |
Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital |
Using circulating biomarkers to identify the patients with hepatocellular carcinoma-based on the samples from National Biobank Consortium of Taiwan |
50 |
20200714 |
|
109085 |
Yen-Hsu Chen |
Medical School, Kaohsiung Medical University |
Development of a rapid diagnosis CMOS of 2019-nCoV |
55 |
20200714 |
|
109086 |
Weng Ching-Fu |
Respiratory Therapy & Chest medicine, Hsinchu Cathay General Hospital |
The role of CAR expression in human lung cancer and analysis the mechanism of respiratory associated virus infection in lung epithelial cell tumorigenesis |
100 |
20200714 |
|
109087 |
Wen-Chi, Yang |
Hematology and medical oncology, E-Da hospital |
Immune landmark in local limited HCC and advanced HCC |
210 |
20200921 |
|
109088 |
Pei-Ing Hwang |
Digital Health Planning Group, Development Center for Biotechnology |
Development of Biomarkers for Precision Medicine with Big Data Analyses |
50 |
20200812 |
|
109089 |
Han-Shui Hsu |
Division of Thoracic Surgery, Taipei Veterans General Hospital |
The Role of Collagen XVII in the Pluripotent Gene Expression and Metabolic Reprogramming of Lung Cancer Stem Cells |
100 |
20200812 |
|
109090 |
Hung-Wei Yang |
Institute of Medical Science and Technology, National Sun Yat-sen University |
A ultrasensitive EasyVial for rapid diagnostic test of viral infections |
90 |
20200714 |
|
109091 |
Chang Wei Li |
AllBio Science, Inc |
The COVID-19 rapid test development |
80 |
20200714 |
|
109092 |
Cheng-Yi Chen |
Department of Cell Biology and Anatomy, National Cheng Kung University |
Investigate the molecular mechanism of protein tyrosine phosphatase IVA3 (PTP4A3) in cisplatin/doxorubicin chemoresistance of hepatocellular carcinoma |
160 |
20200812 |
|
109093 |
Chih-Yang Huang |
Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
Study the genes and molecular mechanisms affecting of colorectal cancer, lung cancer and liver cancer |
39 |
20200812 |
|
109094 |
Chang Yu Ping |
Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital |
Immune biomarkers and pathology correlation in lung adenocarcinoma patients with epidermal growth factor receptor gene mutation and brain metastasis |
60 |
20200812 |
|
109095 |
Po-Hao Feng |
Pulmonary Medicine, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare |
The role and mechanism of CD155/TIGIT in MDSC/TAM induced NK cell dysfunction -A link to lung cancer resistance to immune checkpoint blockade |
40 |
20200812 |
|
109096 |
Tai-Tong Wong |
Neurosurgery, Taipei Medical University Hospital |
Integration of treatment strategies and molecular diagnosis for childhood cancers in Taiwan |
5 |
20200812 |
|
109097 |
Xu, Jia-quan |
Research and Inspection Group Biopharmaceutical Section, Taiwan Food and Drug Administration |
Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation |
40 |
20200812 |
|
109098 |
Ching-Wei Tsai |
Department of Biosensing Development, Helios Bioelectronics Inc. |
Detection of protein from COVID-19 serum samples by semiconductor-based biosensors |
10 |
20200812 |
|
109099 |
Yan-Hwa Wu Lee |
Department of Biological Science and Technology, Tung University |
Center for Intelligent Drug Systems and Smart Bio-devices, IDS2B |
50 |
20200921 |
|
109100 |
Tan Tse-Hua |
Immunology Research Center, NHRI |
Signaling Pathways as Therapeutic Targets for COVID-19 infection |
60 |
20201028 |
|
109101 |
Lung-Wen Tai |
R&D Division, Agnitio Science & Technology, Inc. |
BioIC SARS-CoV2 IgG/IgM Detection Kit-Performance Evaluation |
100 |
20200921 |
|
109102 |
Evelyn Chen |
BioMedical Sensing Business Division, DELBIO, INC. |
COVID-19 IgG/IgM Rapid Test Clinical Trials |
180 |
20200921 |
|
109103 |
Pei-Min Chen |
Pre-clinical and clinical study Dept.,United Biomedical ,Inc.,Asia |
Analysis of immunogenicity in COVID-19 convalescent serum samples |
30 |
20200921 |
|
109104 |
Shu-Chen Kuo |
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes |
Antibody responses to SARS-CoV-2 in patients with COVID-19 |
20 |
20200921 |
|
109105 |
Jyh-Lyh Juang |
Institute of Molecular and Genomic Medicine, National Health Research Institutes |
Identification of potential mechanism for alcohol-induced liver cancer in tumor tissue |
48 |
20201028 |
|
109106 |
Jia-Chuan Hsu |
Section of Biologics, Division of Research and Analysis, Taiwan Food and Drug Administration, Ministry of Health and Welfare |
Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation |
55 |
20201028 |
|
109107 |
Der-Yuan Chen |
Division of Rheumatology and Immunology, China Medical University Hospital |
The associations of hyperferritinemia with disease pathogenesis and COVID-19 infection in rheumatic patients |
30 |
20201119 |
|
109108 |
Ching-Wei Tsai |
Department of Biosensing Development, Helios Bioelectronics Inc. |
Detection of protein from COVID-19 serum samples by semiconductor-based biosensors |
105 |
20201119 |
|
109109 |
Zhong-Zhe Lin |
Medical Oncology, National Taiwan University Cancer Center |
Define the clinicopathologic significance of CpG island methylator phenotype in intrahepatic cholangiocarcinoma |
100 |
20201119 |
|
109110 |
Shih-Jen Liu |
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes |
Development of quantitative rapid test for Covid-19 disease |
70 |
20201119 |
|
109111 |
Hsiang-Tsui Wang |
Department of Pharmacology, National Yang-Ming University |
Using nano-imaging approaches to reveal the interplay of SARS-CoV-2 spike protein with cellular receptors and SARS-CoV-2 spike protein-induced cellular responses |
90 |
20201230 |
|
109112 |
Yahui Huang |
Division of Human Pharmaceuticals and Diagnostics, Schweitzer Biotech Company Ltd. |
Cross Reactivity Study of SBC COVID-19 IgG ELISA Kit |
80 |
20201230 |
|
109113 |
Joe Yeh |
Office of the CEO, English aether AI Co., Ltd. |
AI model of ER、PR、HER-2、Ki-67 in breast cancer |
10 |
20201230 |
|
110114 |
Mei-Ren Pan |
Graduate Institute of Clinical Medicine, Kaohsiung Medical University |
The role of epigenetic modifying enzymes and inhibitors in personalized therapy of breast cancer patients |
2 |
20210222 |
|
110115 |
Yu-Jiun Chan |
Division of Microbiology, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital |
Study of the association among HCMV US28 genotypes and outcome of colorectal patients |
7 |
20210222 |
|
110116 |
Andrew Yueh |
Institute of biotechnology and pharmaceutical research, National Health Research Institute |
Development of next-generation biologics for cancer & immunotherapy therapy Item 1. Development of next-generation antibody drug conjugates |
40 |
20210222 |
|
110117 |
Jia-Chuan Hsu |
Section of Biologics, Division of Research and Analysis, Taiwan Food and Drug Administration, Ministry of Health and Welfare |
Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation |
67 |
20210222 |
|
110118 |
Tzou-Yien Lin |
Department of Pediatrics, Chang Gung Memorial Hospital |
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 |
100 |
20210421 |
|
110119 |
Guann-Yi Yu |
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes |
RNA viral infection and pathogenesis |
35 |
20210421 |
|
110120 |
Yi-Ming Arthur Chen |
Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University |
Using TLCN unlink samples to evaluate the application of novel circulating microRNAs on hepatocellular carcinoma diagnostic and prognostic |
100 |
20210625 |
|
110121 |
Guan-Da Syu |
Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University |
Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray |
60 |
20210625 |
|
110122 |
Hsiang-Ju Chen |
Molecular Virology, LumiSTAR Biotechnology, Inc. |
Development of rapid SARS-CoV-2 Neutralizing Antibody Serologic Detection Kit |
160 |
20210625 |
|
110123 |
Kent Yeh |
Product development department, Avirovac |
SARS-CoV-2 Neutralization Antibody ELISA Development |
60 |
20210625 |
|
110124 |
Yi-Ming Arthur Chen |
Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University |
Study to evaluate the application of novel circulating microRNAs on diagnosis and prognosis of lung cancer |
200 |
20210820 |
|
110125 |
Der-Yuan Chen |
Division of Rheumatology and Immunology, China Medical University Hospital |
The association of anti-cytokine antibodies with disease activity parameters and infection in rheumatic patients |
120 |
20210820 |
|
110126 |
Huang, Yen Chun |
Operation management, Marker Exploration Corp. |
Clinical Utility of Plasma Cancer Proteomic Profile for Early Detecting Lung Cancer |
105 |
20210820 |
|
110127 |
Ching-Fu Weng |
Division of Pulmonary Medicine, Hsinchu Cathay General Hospital |
Detection of airway commensal microbiome in association with lung cancer promotion by whole genome and whole-transcriptome sequencing analyses |
100 |
20210820 |
|
110128 |
Pei-Yi Chu |
Department of Pathology, Show Chwan Memorial Hospital |
To investigate the malignant role of LGR5 in triple-negative breast cancer and develop LGR5 targeted chemotherapy aptamer by Magnetic-Assisted Rapid Aptamer Selection (MARAS) |
12 |
20211007 |
|
110129 |
Po Sheng Yang |
General Surgery, MacKay Memorial Hospital |
Study and Validation for Epstein-Barr virus infection, genes mutation and outcome in breast cancer patients |
2 |
20211007 |
|
110130 |
Hsin-Chou Yang |
Institute of Statistical Science, Academia Sinica |
Establishing NGS analytical model for understanding the infectious program of SARS-CoV-2 |
200 |
20211007 |
|
110131 |
Yahui Huang |
Division of Human Pharmaceuticals and Diagnostics |
Clinical Agreement Study of SBC COVID-19 ELISA |
80 |
20211007 |
|
110132 |
Ruey-Hwa Chen |
Institute of Biological Chemistry, Academia Sinica |
The roles of long noncoding RNA LINAT in tumor progression |
100 |
20211007 |
|
110133 |
Tsai, Jih-Jin |
Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital |
Research and development of COVID-19 precision diagnostics |
120 |
20211217 |
|
110134 |
Kwang-Huei Lin |
Graduate Institutes of Biomedical Sciences, Chang-Gung University |
The clinical significance of thyroid hormone-regulated non-coding RNAs |
120 |
20211217 |
|
110135 |
Ding-Ping Sun |
Department of Surgery, Chi Mei Medical Center |
Clinical impact and carcinogenic mechanism of NCAPG overexpression in colorectal cancer |
36 |
20211217 |
|
110136 |
Mei-Ren Pan |
Graduate Institute of Clinical Medicine, Kaohsiung Medical University |
The role of epigenetic modifying enzymes and inhibitors in personalized therapy of breast cancer patients |
2 |
20211217 |
|
110137 |
Been Ren Lin |
Department of Surgery, National Taiwan University Hospital |
Investigation of molecular mechanism and clinical significance of ATMIN (ataxia telangiectasia mutated interactor) in colorectal cancer with MSS (microsatellite stable) status |
10 |
20211217 |
|
110138 |
Chih-Hao Huang |
Breast Surgical Oncology, China Medical University Hospital |
Exploring the clinical significance of multi-omic markers of young Taiwanese women with triple-negative breast cancer |
10 |
20211217 |
|
110139 |
Sheng-Chi Chang |
Colorectal Surgery, China Medical University Hospital |
Exploring the clinical significance of multi-omic markers of mucinous colorectal adenocarcinoma |
30 |
20211217 |
|
110140 |
Tsu-Yi Chao |
The Graduate Institute of Clinical Medicine, Taipei Medical University |
Investigating the role of BTK/HER2 signaling as a therapeutic target for restoration of T cell function and reversal of Trastuzumab resistance in HER2+ Breast cancer |
8 |
20211217 |
|
110141 |
Yu-Jiun Chan |
Division of Microbiology, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital |
Study of the association among HCMV US28 genotypes and outcome of colorectal patients |
2 |
20211217 |
|
110142 |
Ling-Ming Tseng |
Comprehensive Breast Health Center, Taipei Veterans General Hospital |
Using RNA sequencing to predict the therapeutic response and explore the resistance mechanism for immune checkpoint blockade therapy in patients with triple-negative breast cancer |
12 |
20211217 |
|
111143 |
Jun-Yang Liou |
Institute of Cellular and System Medicine, National Health Research Institutes |
To investigate the role of Nik-related kinase in regulating tumor progression of lung adenocarcinoma (LAC) |
60 |
20220223 |
|
111144 |
Tsai-Ling Liao |
Department of Medical Research,Taichung Veterans General Hospital |
The pathogenic role of extracellular vesicles and cellular factors in COVID-19 |
20 |
20220223 |
|
111145 |
Weng Ching-Fu |
Respiratory Therapy & Chest medicine, Hsinchu Cathay General Hospital |
SLC7A5 in lung cancer as therapeutic target and drug screen platform with analysis of clinical prognostic relevance |
100 |
20220223 |
|
111146 |
Yi-Hsin Yang |
National institute of cancer research, National Health Research Institutes |
Investigate metabolic complications in liver cancer patients treated with target therapies |
6000 |
20220223 |
|
111147 |
Chun Liang Shih |
Panion & BF Biotech inc. |
Evaluation of the detection performance of Vstrip COVID-19 S-RBD Antibody Rapid Test for sera of patients infected with COVID-19 variant strains |
18 |
20220421 |
|
111148 |
Yi-Wen Huang |
CRC, TMUH |
To explore the difference in molecular signature between virus and steatosis-related liver cancer |
1050 |
20220617 |
|
111149 |
CHI-Cheng Huang |
Comprehensive Breast Health Center, Taipei Veterans General Hospital |
New drug development guided from biomedical big data |
2 |
20220617 |
|
111150 |
Chao-Lun Lai |
Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch |
Comparison of neutralizing antibody levels against SARS-CoV-2 variants before and after the third SARS-CoV-2 booster shot |
55 |
20220617 |
|
111151 |
Mei-Hsuan Lee |
Institute of Clinical Medicine, National Yang Ming Chiao Tung University |
Genetic susceptibility and the associated risk of cholangiocarcinoma and non-hepatitis B and non-hepatitis C hepatocellular carcinoma |
300 |
20220718 |
|
111152 |
Tsai-Yuan Hsieh |
Division of Gastroenterology, Tri-Service General Hospital |
To investigate the regulatory mechanisms of CRNDE gene in hepatocellular carcinoma and the clinical significance of its associated molecular expression |
50 |
20220831 |
|
111153 |
Shih-Hsien Hsu |
Graduate Institute of Medicine, Kaohsiung Medical University |
ISX-induced hepatic steatosis impacts the progression of COVID-19 |
100 |
20220831 |
|
111154 |
Shao-Chun Wang |
College of Medicine/ Research Center for Cancer Biology/ Center for Molecular Medicine, China Medical University & Hospital Taiwan, R.O.C. |
Developing novel tumor and blood biomarkers of marker-guided effective cancer therapies |
208 |
20220831 |
|
111155 |
Shu-Chi Wang |
Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University |
Investigation of exosomal DANCR in predicting of HCC recurrence in HCV-related HCC post curative therapy, mechanism of action, and the feasibility on precision medicine application. |
200 |
20220831 |
|
111156 |
Chao-Wei Hsu |
Department of Hepatology and Gastroenterology, Chang Gung Memorial Hospital |
Analyses of Hepatitis Delta Virus Mutants Isolated from Hepatocellular Carcinoma Patients Co-infected with Hepatitis B/D Viruses |
4 |
20220831 |
|
111157 |
Hsiang-Tsui Wang |
Department of Pharmacology, National Yang Ming Chiao Tung University |
Using nano-imaging approaches to reveal the interplay of SARS-CoV-2 spike protein with cellular receptors and SARS-CoV-2 spike protein-induced cellular responses |
250 |
20221017 |
| 111158 | Lai, Tsung-Ching | Division of Pulmonary Medicine, Taipei Municipal Wanfang Hospital | Investigate the contradictory role and function of sphingosine kinases (SPHK1 and SPHK2) in lung adenocarcinoma | 86 | 20221017 |
| 111159 | Hsin-Ling Hsu | Institute of Molecular and Genomic Medicine, National Health Research Institutes | Roles of microRNA-34a and MCT-1 in lipid metabolism during macrophage reprogramming and carcinogenesis | 30 | 20230222 |
| 111160 | Donching Lee | TAQKEY Science Co., Ltd. | DNA methylation for hepatocellular carcinoma | 25 | 20221216 |
| 111161 | Yu-Li Liu | Center for Neuropsychiatric Research, National Health Research Institutes | Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID | 200 | 20221216 |
| 111162 | Tian-Lu Cheng | Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University | Precising the pro-antibody engineering by computer simulation, X-ray crystallography and cryogenic electron microscopy to comprehensively improve the disease selectivity and reduce the side effects of antibody drugs | 50 | 20221216 |
| 111163 | Pei-Jer Chen | Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine | Contribution of HDV in HBV-induced insertional mutagenesis in HBV, HDV-related HCC | 70 | 20221216 |
| 111164 | Cherng Yih-Giun | Superintendent Office,Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare | Identification of Targetable mediators involving in PP1R15B Pathway to Overcome Resistance to Lenvatinib in Drug-Tolerant Persister Liver Cancer | 30 | 20221216 |
| 111165 | Chau-Ting Yeh | School of medicine, Chang-Gung University | Analysis of the role of ApoC1 in hepatocarcinogenesis | 200 | 20221216 |
| 111166 | Jo Ting Tsai | Radiation Oncology, Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare | A mechanism Study of the Interplay between pre-mRNA-SRSF1 and XIRP2 in Radiation Resistance and Metastasis of Hepatocellular Carcinoma | 30 | 20221216 |
| 112167 | Ho, Hsiang-Ling | Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital | To validate the efficacy of microbes infectious and cancer-related biomarkers in vitro diagnostic devices_NSCLC ALK | 20 | Under Review |
| 112168 | Hui-Lin Wu | Hepatitis Research Center, National Taiwan University Hospital | Study on the early recurrence of HBV-associated hepatocellular carcinoma: with emphasis on the molecular mechanisms and clinical implications of a novel metastatic tumor antigen 1 spliced variant, MTA1dE4 hepatocellular carcinoma: with emphasis on the molecular mechanisms and clinical implications of a novel metastatic tumor antigen 1 spliced variant, MTA1dE4 | 150 | 20230222 |
| 112169 | En-Chi Hsu | Institute of Molecular and Genomic Medicine, National Health Research Institutes | Develop Liquid Biopsy-Based Exosomal Correlative Signature Utilizing Oncoprotein-microRNA-circRNA Functional Networks for Early Detection of Liver Cancer | 150 | Under Review |
| 112170 | Chao-Wei Hsu | Department of Hepatology and Gastroenterology, Chang Gung Memorial Hospital | Analyses of Hepatitis Delta Virus Mutants Isolated from Hepatocellular Carcinoma Patients Co-infected withHepatitis B/D Viruses | 70 | 20230222 |
| 112171 | Hu Ching-Wen | Nursing department, Tungs’ Taichung MetroHarbor Hospital | Clinical characteristics of mild COVID-19 with DM patients in Taiwan | 250 | 20230222 |
| 112172 | Shih-Cheng Chen | National Institute Cancer Research, National Health Research Institutes | Validation of genetic variations associated to severe Covid-19 from NBCT data | 250 | 20230419 |
| 112173 | Yu-Li Liu | Center for Neuropsychiatric Research, National Health Research Institutes | Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID | 200 | 20230419 |
| 112174 | Ren-Hua Chung | Institute of Population Health Sciences, National Health Research Institutes | Multi-omics analysis to identify novel immune genes for triple-negative breast cancer and functionally validating their roles in cancer subtyping, tumorigenesis and immune microenvironment | 13 | 20230419 |
| 112175 | Jer-Wei Chang | Precision Medicine and Informatics, Institute Drug Evaluation Platform, Development Center for Biotechnology | Development of Different Cancers Biomarkers for Precision Medicine with Big Data Analyses | 26 | 20230628 |
| 112176 | Tang- Yuan Chu | Department of Obstetric & Gynecology, Tzu Chi Hospital, Hualien | FE25 cell transformation as a serum bioassay to detect cancers and estimate tumor load: a validation study and characterization of the transformation activity | 114 | 20230822 |
| 112177 | Hung-Chih Yang | Internal Medicine, NTUH | Comprehensive Delineation of Oncofetal Ecosystem in Hepatocellular Carcinoma after Hepatectomy | 270 | 20230822 |
| 112178 | Dong-Hao Chen | Research and evelopment department, Sun Jet Biotechnology Inc. | Development of methodology for lung cancer biomarker | 130 | 20231026 |
| 112179 | Wen-Hui Su | Department of Biomedical Sciences, Chang Gung University | Feasibility Assessment of Polygenic Risk Score-Stratified Screening in Hepatocellular Carcinoma | 600 | 20231026 |
| 112180 | Yang-His Tsai | Integrative Genomic Diagnostics, Chung-Yi Medical Laboratory | Pan Cancer Molecular Biomarker in Solid Tumors Validation Plan | 29 | 20231213 |
| 112181 | Kun-Yu Lai | Department of Optics and Photonics, National Central University | High throughput Raman spectroscopy: A new DNA testing for cancers and cord blood | 10 | 20231213 |
| 112182 | Yu-Li Liu | Center for Neuropsychiatric Research, National Health Research Institutes | Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID | 200 | 20231213 |
| 112183 | Yu-Li Liu | Center for Neuropsychiatric Research, National Health Research Institutes | Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID | 250 | 20231213 |
| 113184 | Huamei Chang | Research & Development, SP BioMED Co. Ltd. | Polygenic risk score for early onset breast cancer of Taiwan | 13 | 20240227 |
| 113185 | Joe Yeh | Office of the CEO, aetherAI Co., Ltd. | Classification model of me staining in lung cancer and urothelial carcinoma | 30 | 20240227 |
| 113186 | Guan-Da Syu | Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University | Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray | 60 | 20240227 |
| 113187 | Hui-Lin Wu | Hepatitis Research Center, National Taiwan University Hospital | Investigating the roles and molecular mechanisms of the major vault protein (MVP) in hepatocellular carcinoma induced by HBV (hepatitis B virus) and HBV with concurrent metabolic dysfunction-associated steatotic liver disease (MASLD) | 200 | 20240418 |
| 113188 | Tung-Hung Su | Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital | Clinical utility of laminin γ2 monomer (LG2m) in prognosing extrahepatic spread (EHS) of tumor in early to intermediate stage hepatocellular carcinoma (HCC) patients | 240 | 20240418 |
| 113189 | Ming-Shiu Hung | Institute of Biotechnology & Pharmaceutical Research, National Health Research Institutes | Orphan G protein-coupled receptor in the pathogenesis of liver fibrosis | 15 | 20240614 |
| 113190 | Chau Ting Yeh | Gastroenterology,Hepatobiliary and Biology, Chang Gung Memorial Hospital,Linkou | Genetic and virological factors in the cirrhotic liver in association with hepatocellular carcinoma postoperative prognosis | 30 | 20240614 |
| 113191 | Shiou-Hwei Yeh | Graduate Institute of Microbiology, National Taiwan University College of Medicine | New immunotherapies for chronic hepatitis B and hepatocellular carcinoma — Subproject 4: Driver mutations in HBV-infected hepatocytes enabling immune-escape and tumorigenesis: mechanisms and therapeutic targets | 185 | 20240813 |
| 113192 | Kuo-Sheng Liao | Department of Pathology, Taoyuan General Hospital, Ministry of Health and Welfare | The role of protein phosphatase deficiency in liver cell junction defects and cancers | 80 | 20240813 |
| 113193 | Ming-Hui Lin | Department of Gastroenterology, Taoyuan General Hospital, Ministry of Health and Welfare | Establishing a zebrafish model to study the molecular mechanisms of NASH and NASH associated HCC toward develop therapies | 150 | 20240813 |
| 113194 | YU-SHAN WANG | General Manager Office,UniPharma Co.,Ltd. | Analysis of the differential expression of the DR-70 tumor marker in various cancer patients compared to a healthy population, utilizing serum samples from the National Biobank Consortium of Taiwan | 114 | 20240813 |
| 113195 | Mei-Hsuan Lee | Institute of Clinical Medicine, National Yang Ming Chiao Tung University | Identifying Protein Biomarkers for Early Detection of Hepatobiliary Cancers | 400 | 20241022 |
| 113196 | Ming-Wei Lai | Pediatric,Linkou Chang Gung Memorial Hospital | Investigating Extracellular Vesicles and Their Role in Hepatitis B Virus-Related Liver Disease Progression | 40 | 20241022 |
| 113197 | Ming-Wei Lai | Pediatric,Linkou Chang Gung Memorial Hospital | Identification and characterization of novel biomarkers of response to targeted therapy in patients with advanced HBV-related hepatocellular carcinoma | 40 | 20241022 |
| 113198 | Wey-Ran Lin | Gastroenterology, Linkou Chang Gung Memorial Hospital | To identify the potential biomarkers in advanced hepatocellular carcinoma: using circulating and exosomal mitochondrial DNA and their mutations | 40 | 20241023 |
| 113199 | Ya-Hsuan Chang | Institute of Molecular and Genomic Medicine, National Health Research Institute | Derivation and validation of prognostic prediction models in patients with intermediate and advanced hepatocellular carcinoma based on GALNT14 genotype | 4000 | 20241022 |